We are live on ! Find out more
PI

Placemark Investments Portfolio holdings

AUM $5.66B
1-Year Est. Return 10.93%
This Fund
S&P 500
This Quarter Est. Return
+4.77%
1 Year Est. Return
+10.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.66B
AUM Growth
+$246M
Cap. Flow
+$52.3M
Cap. Flow %
0.92%
Top 10 Hldgs %
8.96%
Holding
1,753
New
125
Increased
873
Reduced
618
Closed
135

Sector Composition

Rank Sector Weight
1 Healthcare 10.99%
2 Financials 10.82%
3 Technology 10.74%
4 Industrials 8.28%
5 Consumer Discretionary 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MUB icon
126
iShares National Muni Bond ETF
MUB
$45B
$10.5M 0.19%
95,198
+27,624
+41% +$3.04M
NOV icon
127
NOV
NOV
$7.22B
$10.4M 0.18%
158,916
+63,431
+66% +$4.42M
TEL icon
128
TE Connectivity
TEL
$58B
$10.2M 0.18%
161,576
+46,695
+41% +$2.81M
ACWX icon
129
iShares MSCI ACWI ex US ETF
ACWX
$11.4B
$10.2M 0.18%
237,344
+33,000
+16% +$1.46M
AIG icon
130
American International
AIG
$41.4B
$10.2M 0.18%
182,236
+12,296
+7% +$660K
NVO
131
Novo Nordisk
NVO
$213B
$10.2M 0.18%
480,100
-2,518
-0.5% -$56.2K
STX icon
132
Seagate
STX
$207B
$10.1M 0.18%
152,440
+39,494
+35% +$2.45M
COF icon
133
Capital One
COF
$123B
$10.1M 0.18%
122,267
+6,102
+5% +$496K
BA icon
134
Boeing
BA
$165B
$10.1M 0.18%
77,427
+296
+0.4% +$37.5K
RDS.A
135
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$10M 0.18%
149,564
-8,277
-5% -$573K
MJN
136
DELISTED
Mead Johnson Nutrition Company
MJN
$9.93M 0.18%
98,766
+4,403
+5% +$439K
ECL icon
137
Ecolab
ECL
$74.1B
$9.9M 0.17%
94,749
-4,595
-5% -$503K
JNK icon
138
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
$9.8M 0.17%
84,602
-36,042
-30% -$4.28M
AMGN icon
139
Amgen
AMGN
$201B
$9.7M 0.17%
60,896
+33,812
+125% +$5.27M
TXN icon
140
Texas Instruments
TXN
$259B
$9.64M 0.17%
180,237
+5,000
+3% +$253K
CLB icon
141
Core Laboratories
CLB
$544M
$9.62M 0.17%
79,967
+55,987
+233% +$7.35M
DBEF icon
142
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.08B
$9.53M 0.17%
352,914
+155,484
+79% +$4.28M
BCE icon
143
BCE
BCE
$19.8B
$9.48M 0.17%
206,797
+38,499
+23% +$1.73M
DGX icon
144
Quest Diagnostics
DGX
$25.2B
$9.47M 0.17%
141,271
+24,218
+21% +$1.53M
TMO icon
145
Thermo Fisher Scientific
TMO
$213B
$9.47M 0.17%
75,558
-3,005
-4% -$365K
PSX icon
146
Phillips 66
PSX
$83B
$9.45M 0.17%
131,736
+49,109
+59% +$3.62M
AGN
147
DELISTED
Allergan Inc
AGN
$9.43M 0.17%
44,357
-16,041
-27% -$3.19M
EOG icon
148
EOG Resources
EOG
$77.5B
$9.43M 0.17%
102,376
+13,597
+15% +$1.27M
VRSK icon
149
Verisk Analytics
VRSK
$25.3B
$9.32M 0.16%
145,537
+13,711
+10% +$854K
HBI
150
DELISTED
Hanesbrands
HBI
$9.28M 0.16%
332,576
-26,368
-7% -$723K

Similar funds

Placemark Investments's Q4 2014 Portfolio in Review

As of Q4 2014, Placemark Investments held 1,753 positions worth $5.66B, up 4.5% from $5.41B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Placemark Investments's Q4 2014 filing shows 125 new, 873 increased, 618 reduced and 135 closed positions. Its largest new stake was First Trust Utilities AlphaDEX Fund: 669,538 shares worth $16.7M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • Placemark Investments's largest Q4 2014 buy was First Trust Utilities AlphaDEX Fund: 669,538 shares worth $16.7M.
  • Placemark Investments added most to iShares US Financials ETF in Q4 2014, an estimated $38.2M increase.
  • Placemark Investments's biggest Q4 2014 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $62.8M.
  • Placemark Investments fully exited Walgreens Boots Alliance in Q4 2014, selling an estimated $5.89M.
  • Placemark Investments's ten largest holdings make up 9% of its $5.66B portfolio in Q4 2014.
  • Placemark Investments opened 125 new positions and closed 135 in Q4 2014.
  • Placemark Investments's portfolio value rose 4.5% quarter-over-quarter to $5.66B.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.